KPRX

KioraC

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Current thesis

Composite grade C from latest DB weights. Momentum 26.4 / Value 56.8

Posture

Mixed

Lead driver

Value

What changed

Next scheduled catalyst: earnings 2026-11-05.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.

Earnings

2026-11-05

Data freshness

Prices

Unavailable: Price unavailable

Fundamentals

As of 2026-10-29 • Vendor: Data Vendor v1

Scores

As of 2026-10-29 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-10-29

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions

Supporting evidence

What

Grade C · Mixed

Confidence Medium · Net Neutral

Target $12.00

Why

Momentum26 · Δ7d -

Value57 · Δ7d -0.5

SentimentN/A · Δ7d -

So what

Balanced signals (Net Neutral). Wait for confirmation before sizing up.

Confirming evidence

• Next scheduled catalyst: earnings 2026-11-05.
• Value remains the lead driver in the composite, 7D delta -0.5.

Contradictions & invalidation

• Mixed signals. Wait for cleaner trend confirmation.

Catalyst clock

2026-11-05

Lead driver: Value · See fundamentals

Momentum

15% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

85% active weight

Current posture

7d trendFlat

Δ7d

-0.5

Δ21d

-0.8

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade C. Momentum 26.4 / Value 56.8

Fundamentals (TTM)

As of 2026-10-29

Market Cap

$7.79M

Beta

-0.83

Shares Out

4.42M

P/E (TTM) · Derived

-0.7

P/S (TTM)

P/FCF (TTM)

0.90

Rev YoY

-100.0%

EPS YoY

-37.6%

Gross Margin

-245.5%

Op Margin

-55731.7%

Net Debt

-$16.72M

Current Ratio

8.97

As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data